Ceribell CFO Scott Blumberg sells over $863k in company stock

Ceribell CFO Scott Blumberg sold 34,502 shares of company stock, totaling approximately $863,555, on August 18 and 19, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan. On August 18, Blumberg sold 990 shares at $25 per share each, followed by 33,512 shares on August 19 at a weighted average price of $25.03.

Ceribell's shares are trading near a 52-week high of $25.33, with an 108% return over the past year, though the stock is considered overvalued by InvestingPro. Prior to selling, Blumberg purchased 34,502 shares at prices ranging from $4.70 to $9.41, resulting in a total value of $292,310. Following these sales, Blumberg owns 148,121 shares of Ceribell common stock, including shares from the Issuer’s Employee Stock Purchase Plan.

Ceribell reported a 33% increase in revenue to $28.1 million in its second quarter, but posted a loss of $0.51 per share, wider than expected. Analysts maintain a Buy rating for Ceribell, citing strong performance in point-of-care rapid EEG technology.